日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

INDUCE-3:一项随机 II/III 期研究,评估一线 Feladilimab 联合 Pembrolizumab 治疗复发/转移性头颈部鳞状细胞癌患者的疗效

Rischin, Danny; Hansen, Aaron R; Cohen, Ezra E W; Tahara, Makoto; Harrington, Kevin J; Haddad, Robert I; Licitra, Lisa; Mehanna, Hisham; Ferris, Robert L; Koralewski, Piotr; Penkov, Konstantin; Schenker, Michael; Spigel, David R; Daste, Amaury; Hong, Min Hee; Guo, Ye; Chisamore, Michael J; Washburn, Michael L; Phillips-Jones, Amy; Russell, John; Roy-Ghanta, Sumita; Ellis, Catherine; Ballas, Marc; Le Tourneau, Christophe

Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma

研究血浆ctDNA和外周T细胞受体库的早期动力学以预测头颈部鳞状细胞癌患者对PD-1抑制剂的治疗结果

Sanz-Garcia, Enrique; Soleimani, Shirin; Bruce, Jeff P; Pedersen, Stephanie; Tang, Marian; Avery, Lisa; Eagles, Jenna; Spreafico, Anna; Hansen, Aaron R; Eng, Lawson; Laliotis, George; Krainock, Michael; Liu, Minetta; Basra, Prabhjit; Yu, Celeste; Felicen, Sam; Ohashi, Pamela S; Bratman, Scott V; Pugh, Trevor J; Siu, Lillian L

Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab

组织非特异性全基因组甲基化组富集检测方法的临床验证,用于监测帕博利珠单抗的疗效

Stutheit-Zhao, Eric Y; Zhong, Yongqi; Melton, Collin A; Lightbody, Elizabeth D; Hinterberg, Michael A; Wang, Yarong; Hall, Owen; Sosa, Eduardo V; Provance, Jeremy B; Zhang, Junjun; Licon, Abel; Liu, Zhihui Amy; Abdul Razak, Albiruni R; Spreafico, Anna; Bedard, Philippe L; Hansen, Aaron R; Lheureux, Stephanie; Ohashi, Pamela S; Williams, Alan; Bratman, Scott V; Allen, Brian A; Zhang, Jing; De Carvalho, Daniel D; Hartman, Anne-Renee; Siu, Lillian L; Sanz-Garcia, Enrique

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR

早期剂量探索性肿瘤试验中患者报告结局研究目标的国际共识驱动建议:OPTIMISE-ROR

Alger, Emily; Aiyegbusi, Olalekan Lee; Dueck, Amylou C; Minchom, Anna; Pe, Madeline; Peipert, John D; Snyder, Claire; Symeonides, Stefan N; Wilson, Roger; Basch, Ethan; Qiao, Yu; Bates, Susan E; Bulbeck, Helen; Dean, Lizzie; Di Maio, Massimo; Hansen, Aaron R; Kholmanskikh, Olga; Kobayashi, Ken; Landers, Dónal; Le Tourneau, Christophe; Lee, J Jack; Ma, Brigette B Y; Marshall, Lynley V; Patel, Sheetal; Petrie, Joan; Pond, Gregory R; Prior, Kieran; Rantell, Khadija R; Reeve, John F; Solovyeva, Olga; Wages, Nolan A; Weber, Harald A; Calvert, Melanie J; Yap, Christina

A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer

JNJ-70218902(一种针对TMEFF2的双特异性T细胞重定向抗体)在转移性去势抵抗性前列腺癌中的首次人体研究

Calvo, Emiliano; Doger, Bernard; Carles, Joan; Peer, Avivit; Sarid, David; Eigl, Bernhard J; Avadhani, Anjali; Yao, David; Lin, Vincent; Wu, Shujian; Jaiprasart, Pharavee; Loffredo, John; Tamegnon, Monelle; Xu, Weichun; Xie, Hong; Hansen, Aaron R

Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors.

Copanlisib 与 Nivolumab 联合治疗晚期实体瘤患者的安全性和有效性:一项 Ib 期研究

Carneiro Benedito A, Jotte Robert M, Gabrail Nashat Y, Wentzel Kristopher, Huang Funan, Chaturvedi Shalini, Weispfenning Anke, Hiemeyer Florian, Morcos Peter N, Mongay Soler Lidia, Childs Barrett H, Hansen Aaron R

Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors

肿瘤初始状态下游离甲基化组和片段组的早期变化可预测帕博利珠单抗治疗实体瘤的预后

Stutheit-Zhao, Eric Y; Sanz-Garcia, Enrique; Liu, Zhihui Amy; Wong, Derek; Marsh, Kayla; Abdul Razak, Albiruni R; Spreafico, Anna; Bedard, Philippe L; Hansen, Aaron R; Lheureux, Stephanie; Torti, Dax; Lam, Bernard; Yang, Shih Yu Cindy; Burgener, Justin; Luo, Ping; Zeng, Yong; Cheng, Nicholas; Awadalla, Philip; Bratman, Scott V; Ohashi, Pamela S; Pugh, Trevor J; Siu, Lillian L

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable

推进以患者为中心的医疗服务:将患者报告结局纳入早期临床试验耐受性评估——专家虚拟圆桌会议的见解

Yap, Christina; Lee Aiyegbusi, Olalekan; Alger, Emily; Basch, Ethan; Bell, Jill; Bhatnagar, Vishal; Cella, David; Collis, Philip; Dueck, Amylou C; Gilbert, Alexandra; Gnanasakthy, Ari; Greystoke, Alastair; Hansen, Aaron R; Kamudoni, Paul; Kholmanskikh, Olga; King-Kallimanis, Bellinda L; Krumholz, Harlan; Minchom, Anna; O'Connor, Daniel; Petrie, Joan; Piccinin, Claire; Rantell, Khadija Rerhou; Rauz, Saaeha; Retzer, Ameeta; Rizk, Steven; Wagner, Lynne; Sasseville, Maxime; Seymour, Lesley K; Weber, Harald A; Wilson, Roger; Calvert, Melanie; Peipert, John Devin

Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab

转录组和循环肿瘤DNA纵向生物标志物联合分析与接受帕博利珠单抗治疗的晚期实体瘤患者的临床结果相关

Hernando-Calvo, Alberto; Yang, S Y Cindy; Vila-Casadesús, Maria; Han, Ming; Liu, Zhihui Amy; Berman, A Hal K; Spreafico, Anna; Razak, Albiruni Abdul; Lheureux, Stephanie; Hansen, Aaron R; Lo Giacco, Deborah; Abbas-Aghababazadeh, Farnoosh; Matito, Judith; Haibe-Kains, Benjamin; Pugh, Trevor J; Bratman, Scott V; Aleshin, Alexey; Berche, Roger; Saavedra, Omar; Garralda, Elena; Elston, Sawako; Siu, Lillian L; Ohashi, Pamela S; Vivancos, Ana; Bedard, Philippe L

Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial

经口机器人手术联合放射治疗体积减密度技术治疗颈部原发灶不明的鳞状细胞癌:FIND 2期非随机对照试验

de Almeida, John R; Martino, Rosemary; Hosni, Ali; Goldstein, David P; Bratman, Scott V; Chepeha, Douglas B; Waldron, John N; Weinreb, Ilan; Perez-Ordonez, Bayardo; Yu, Eugene; Metser, Ur; Hansen, Aaron R; Xu, Wei; Su, Susie Jie; Kim, John